4th Quarter - Report

BOCKORNY GROUP, INC. for CVS HEALTH INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Labor Issues/Antitrust/Workplace LBR

Issues related to anti-trust and merger activity

LobbyistCovered position, as disclosed
BERNARD ROTHSCHILD —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Issues Related to restructuring of corporate tax rates - no specific legislation H.R.1314 - Bipartisan Budget Act of 2015 H.R.2029 - Consolidated Appropriations Act, 2016 Issues Related to international tax policy Issues Related to the tax relief package Issues Related to the taxes on employee health plans

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
CAROLYN MAYLE —
NICOLE VENABLE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1314 (114th), H.R. 2029 (114th)

Health Issues HCR

H.R.6 - 21st Century Cures Act H.R.793 - Ensuring Seniors Access to Local Pharmacies Act of 2015 H.R.1314 - Bipartisan Budget Act of 2015 H.R.2029 - Consolidated Appropriations Act, 2016 Issues related to the corporate business model, smoking cessation, Medicare Part D and anti-PBM legislation Issues related to health care delivery system reforms including telehealth, cost containment, medication adherence, restrictions on PBM cost saving tools like mail order, generics and restrictions on PBM audit practices Privacy issues relating to the use of protected health information Issues related to Federal Employees Health Benefit Plan Issues related to Medicare/Medicaid plan design, reimbursement, cost savings proposals, and SGR Issues related to home infusion

LobbyistCovered position, as disclosed
CAROLYN MAYLE —
NICOLE VENABLE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6 (114th), H.R. 1314 (114th), H.R. 2029 (114th), H.R. 793 (114th)

Pharmacy PHA

Issues related to PBM's - no specific legislation Issues related to preferred pharmacy networks, mail order and incentives Issues related to prescription drug abuse, pharmacist provider status, drug pricing and drug supply chain safety. H.R.1600 - A bill to amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes. H.R.804 - Expanding the Availability of Medicare Data Act H.R.592 - Pharmacy and Medically Underserved Areas Enhancement Act S.314 - Pharmacy and Medically Underserved Areas Enhancement Act H.R.244 - MAC Transparency Act H.R.1021 - Protecting the Integrity of Medicare Act of 2015 S.776 - Medication Therapy Management Empowerment Act of 2015 H.R.471 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 S.483 - Ensuring Patient Access and Effective Drug Enforcement Act of 2015 Issues related to anti-PBM issues

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
CAROLYN MAYLE —
NICOLE VENABLE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1021 (114th), H.R. 804 (114th), H.R. 592 (114th), S. 314 (114th), S. 483 (114th), H.R. 244 (114th), S. 776 (114th), H.R. 1600 (114th), H.R. 471 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.